Skip to main content

EN
ÍS

Forsíða

Forsíða

Þórdís Jóna Hrafnkelsdóttir - Dósent

Þórdís Jóna Hrafnkelsdóttir

–

Heilbrigðisvísindasvið

Þórdís Jóna Hrafnkelsdóttir

Dósent

Kennslustjóri Læknadeildar

Sími
8245762 8245762
Tölvupóstur
tjonah [hjá] hi.is

Starfseining
Læknadeild

ORCID vefsíða
https://orcid.org/0000-0002-4398-2898
Rannsóknagátt – Þórdís Jóna Hrafnkelsdóttir

Útgefið efni

2024

Cohort profileEuropean Heart Journal - Quality of Care and Clinical Outcomes
Diagnostic and therapeutic practice for HFpEF across continents and regionsESC heart failure
Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measuresEuropean heart journal. Quality of care & clinical outcomes
Definitions of clinical study outcome measures for cardiovascular diseasesEuropean heart journal

2022

Improving outpatient care for heart failure through digital innovationPilot and Feasibility Studies
Hjartaígræðslur og hjartagjafir ÍslendingaLæknablaðið

2020

The Establishment of the Nordic Cardio-Oncology SocietyJACC: CardioOncology
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast CancerCurrent Heart Failure Reports

2019

Roadmap for cardiovascular education across the European Society of CardiologyEuropean Heart Journal

2018

Árangur kransæðahjáveituaðgerða hjá konum á ÍslandiLæknablaðið
Árangur kransæðahjáveituaðgerða hjá konum á ÍslandiLæknablaðið

2016

Ghid de management al endocarditei infecţioase 2015Revista Romana de Cardiologie
Kransæðasjúkdómur í konum
Einkenni kransæðasjúkdóms

2015

Successful Treatment of Nocardia Farcinica Prosthetic Valvular Endocarditis without Valvular ReplacementAmerican Journal of Medical Case Reports

2014

Profibrinolytic effect of the epigenetic modifier valproic acid in manPLoS ONE

2013

Acute vascular effects of atorvastatin in hypertensive menScandinavian Cardiovascular Journal

2012

Goðsögnin um hjartasjúkdóma sem karlaveiki.

2011

Ósæarlokuskipti - á leið inn í nýja tíma?Laeknabladid
The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure loweringJournal of Thrombosis and Thrombolysis
Osædarlokusipti -- á leid inn í nýja tíma?Læknabladid

2010

Consistency of blood pressure and impact on cardiovascular structure over 20 years in young menJournal of Internal Medicine
Transcutaneous electrical nerve stimulation induces vasodilation in healthy controls but not in refractory angina patientsJournal of Pain and Symptom Management
Response to letter to editor by Jolobe 'Results have relevance for resolving discrepancies in the approach to population screening'Journal of Internal Medicine

2007

Local tissue-type plasminogen activator release in patients with ischemic stroke [1]Journal of Thrombosis and Haemostasis
ST segment elevation and chest pain during cryoablation of atrial flutterEuropace

2006

TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependentJournal of Thrombosis and Haemostasis
Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapyHypertension

2005

Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cellsJournal of Hypertension

2004

Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertensionHypertension
Regulation of local availability of active tissue-type plasminogen activator in vivo in manJournal of Thrombosis and Haemostasis

2003

Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffectedThrombosis and Haemostasis

2001

Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in manThrombosis and Haemostasis

2000

Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjectsBlood Pressure
Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expressionHypertension

1999

Desmopressin-induced release of Tissue-Type Plasminogen Activator (t-PA) in human forearm is not influenced by nitric oxide synthesis inhibitionFibrinolysis and Proteolysis

1998

Impaired capacity for endogenous fibrinolysis in essential hypertensionLancet
Impaired release of tissue-type plasminogen activator (t-PA) from vascular endothelium in essential hypertensionFibrinolysis and Proteolysis

Sérsvið:

Hjarta- og æðasjúkdómar